Van Rijssen, Thomas J., Van Dijk, Elon H.c., Yzer, Suzanne, Ohno-matsui, Kyoko, Keunen, Jan E.E., Schlingemann, Reinier O., Sivaprasad, Sobha, Querques, Giuseppe, Downes, Susan M., Fauser, Sascha, Hoyng, Carel B., Piccolino, Felice Cardillo, Chhablani, Jay K., Lai, Timothy Y.Y., Lotery, Andrew J., Larsen, Michael, Holz, Frank G., Freund, K. Bailey, Yannuzzi, Lawrence A. and Boon, Camiel J.F. (2019) Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research. (doi:10.1016/j.preteyeres.2019.07.003).
Abstract
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily affecting men 20–60 years of age. To date, no consensus has been reached regarding the classification of CSC, and a wide variety of interventions have been proposed, reflecting the controversy associated with treating this disease. The recent publication of appropriately powered randomised controlled trials such as the PLACE trial, as well as large retrospective, non-randomised treatment studies regarding the treatment of CSC suggest the feasibility of a more evidence-based approach when considering treatment options. The aim of this review is to provide a comprehensive overview of the current rationale and evidence with respect to the variety of interventions available for treating CSC, including pharmacology, laser treatment, and photodynamic therapy. In addition, we describe the complexity of CSC, the challenges …
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.